Abstract
The phosphatidylinositol-3-kinase (PI3K) signaling pathway plays an important role in tumorigenesis. One of the most common somatic mutations of PI3K in the p110a subunit (PIK3CA) occurs in various types of solid tumors. The presence of PIK3CA is associated with shorter survival and resistance to chemotherapy and radiation therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
